Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cilostazol for Secondary Prevention of Stroke and Cognitive Decline
Caroline McHutchison, Gordon W. Blair, Jason P. Appleton, et al.
Stroke (2020) Vol. 51, Iss. 8, pp. 2374-2385
Open Access | Times Cited: 82

Showing 1-25 of 82 citing articles:

ESO Guideline on covert cerebral small vessel disease
Joanna M. Wardlaw, Stéphanie Debette, Hanna Jokinen, et al.
European Stroke Journal (2021) Vol. 6, Iss. 2, pp. CXI-CLXII
Open Access | Times Cited: 116
The Potential Impact of Neuroimaging and Translational Research on the Clinical Management of Lacunar Stroke
Salvatore Rudilosso, Alejandro Rodríguez-Vázquez, Xabier Urra, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1497-1497
Open Access | Times Cited: 101
Isosorbide Mononitrate and Cilostazol Treatment in Patients With Symptomatic Cerebral Small Vessel Disease
Joanna M. Wardlaw, Lisa J Woodhouse, Iris Mhlanga, et al.
JAMA Neurology (2023) Vol. 80, Iss. 7, pp. 682-682
Open Access | Times Cited: 66
European stroke organisation (ESO) guideline on cerebral small vessel disease, part 2, lacunar ischaemic stroke
Joanna M. Wardlaw, Hugues Chabriat, Frank‐Erik de Leeuw, et al.
European Stroke Journal (2024) Vol. 9, Iss. 1, pp. 5-68
Open Access | Times Cited: 17
Cilostazol: a Review of Basic Mechanisms and Clinical Uses
Riyad Yazan Kherallah, Muzamil Khawaja, M.T. Olson, et al.
Cardiovascular Drugs and Therapy (2021) Vol. 36, Iss. 4, pp. 777-792
Closed Access | Times Cited: 60
Antiplatelet Use in Ischemic Stroke
Marharyta Kamarova, Sheharyar Baig, Hamish Patel, et al.
Annals of Pharmacotherapy (2022) Vol. 56, Iss. 10, pp. 1159-1173
Open Access | Times Cited: 44
Improvement of poststroke cognitive impairment by intermittent theta bursts: A double‐blind randomized controlled trial
Wen Li, Qian Wen, Yu‐Han Xie, et al.
Brain and Behavior (2022) Vol. 12, Iss. 6
Open Access | Times Cited: 40
Antithrombotic Therapy for Primary and Secondary Prevention of Ischemic Stroke
Antonio Greco, Giovanni Occhipinti, Daniele Giacoppo, et al.
Journal of the American College of Cardiology (2023) Vol. 82, Iss. 15, pp. 1538-1557
Open Access | Times Cited: 28
Secondary Ischemic Stroke Prevention
Aaron Bangad, Mehdi Abbasi, Adam de Havenon
Neurotherapeutics (2023) Vol. 20, Iss. 3, pp. 721-731
Open Access | Times Cited: 26
Contemporary Antiplatelet and Anticoagulant Therapies for Secondary Stroke Prevention: A Narrative Review of Current Literature and Guidelines
Kunal Bhatia, Lindsey Ladd, Kelsey Carr, et al.
Current Neurology and Neuroscience Reports (2023) Vol. 23, Iss. 5, pp. 235-262
Closed Access | Times Cited: 26
Blood–brain crosstalk: the roles of neutrophils, platelets, and neutrophil extracellular traps in neuropathologies
Ming‐Li Chou, Babamale Olarewaju Abdulkareem, Tara L. Walker, et al.
Trends in Neurosciences (2023) Vol. 46, Iss. 9, pp. 764-779
Closed Access | Times Cited: 24
The Role of Cilostazol, a Phosphodiesterase-3 Inhibitor, in the Development of Atherosclerosis and Vascular Biology: A Review with Meta-Analysis
Minji Sohn, Soo Lim
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2593-2593
Open Access | Times Cited: 10
Cerebral Vascular Dysfunctions Detected in Human Small Vessel Disease and Implications for Preclinical Studies
Joanna M. Wardlaw, Helene Benveniste, Anna Williams
Annual Review of Physiology (2021) Vol. 84, Iss. 1, pp. 409-434
Open Access | Times Cited: 43
Antiplatelet Resistance: A Review of Concepts, Mechanisms, and Implications for Management in Acute Ischemic Stroke and Transient Ischemic Attack
Kailash Krishnan, Thanh N. Nguyen, Jason P. Appleton, et al.
Stroke Vascular and Interventional Neurology (2023) Vol. 3, Iss. 3
Open Access | Times Cited: 18
Current and Future Treatments of Vascular Cognitive Impairment
Bonaventure Ip, Ho Ko, Bonnie Yin Ka Lam, et al.
Stroke (2024) Vol. 55, Iss. 4, pp. 822-839
Closed Access | Times Cited: 7
Cilostazol for Secondary Stroke Prevention
Adam de Havenon, Kevin N. Sheth, Tracy E. Madsen, et al.
Stroke (2021) Vol. 52, Iss. 10
Open Access | Times Cited: 33
Contemporary antiplatelet therapy for secondary stroke prevention: a narrative review of current literature and guidelines
Jay Shah, Shimeng Liu, Wengui Yu
Stroke and Vascular Neurology (2022) Vol. 7, Iss. 5, pp. 406-414
Open Access | Times Cited: 25
Dual Antiplatelet Therapy With Cilostazol for Secondary Prevention in Lacunar Stroke: Subanalysis of the CSPS.com Trial
Yasuhiro Nishiyama, Kazumi Kimura, Toshiaki Otsuka, et al.
Stroke (2023) Vol. 54, Iss. 3, pp. 697-705
Open Access | Times Cited: 15
New options for cilostazol-based dual antiplatelet therapy for ischaemic stroke prevention in East Asian populations: a systematic review and meta-analysis
Xiaorui Wang, Yixin Wang, Qiang Zheng, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Efficacy and safety of using cilostazol versus aspirin in secondary stroke prevention: systematic review and meta‐analysis of randomised controlled clinical trials
Ping Zhuang, Yü Huang, Zuncheng Zheng, et al.
Internal Medicine Journal (2025)
Open Access
Prevalence of Aspirin or Clopidogrel Pharmacological Resistance in Ischemic Stroke: A Step Toward Precision Medicine
Samantha Cencer, Laurel Packard, Alan T. Davis, et al.
CNS Neuroscience & Therapeutics (2025) Vol. 31, Iss. 3
Open Access
CILO-CLOP Trial: Cilostazol Versus Clopidogrel in Acute Moderate and Moderate-to-Severe Ischemic Stroke: A Randomized Controlled Multicenter Trial
Mohamed G. Zeinhom, Mohamed Ismaiel, Mohamed Fouad Elsayed Khalil, et al.
Neurology and Therapy (2025)
Open Access
Advances in Recurrent Stroke Prevention: Focus on Antithrombotic Therapies
Brian Mac Grory, Shadi Yaghi, Charlotte Cordonnier, et al.
Circulation Research (2022) Vol. 130, Iss. 8, pp. 1075-1094
Open Access | Times Cited: 19
Efficacy, Safety, and Role of Antiplatelet Drugs in the Management of Acute Coronary Syndrome: A Comprehensive Review of Literature
Muhammad Abubakar, Saud Raza, Khawaja Mushammar Hassan, et al.
Cureus (2023)
Open Access | Times Cited: 12
Antiplatelet strategies: past, present, and future
Livia Stanger, Adriana Yamaguchi, Michael Holinstat
Journal of Thrombosis and Haemostasis (2023) Vol. 21, Iss. 12, pp. 3317-3328
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top